Shandong Pharmaceutical Glass Co.Ltd (SHA:600529)
17.95
+0.02 (0.11%)
Nov 19, 2026, 9:35 AM CST
SHA:600529 Revenue
Shandong Pharmaceutical Glass Co.Ltd had revenue of 968.82M CNY in the quarter ending September 30, 2026, a decrease of -12.07%. This brings the company's total for the last twelve months to 4.37B, down -1.37% year-over-year. In the year 2025, Shandong Pharmaceutical Glass Co.Ltd had annual revenue of 4.47B, down -8.78%. That makes Shandong Pharmaceutical Glass Co.Ltd the 9,777th largest company in the world by revenue and 1,570th in China.
Revenue (ttm)
4.37B
Revenue Growth
-1.37%
P/S Ratio
2.72
Revenue / Employee
645.19K
Employees
6,775
Market Cap
11.91B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHA:600529 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.47B | -430.89M | -8.78% |
| Dec 31, 2024 | 4.90B | -77.29M | -1.55% |
| Dec 31, 2023 | 4.98B | 794.92M | 18.98% |
| Dec 31, 2022 | 4.19B | 311.97M | 8.05% |
| Dec 31, 2021 | 3.88B | 448.24M | 13.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| ORG Technology | 26.34B |
| Shanghai Zijiang Enterprise Group | 9.20B |
| Xiamen Jihong | 7.47B |
| Jiangsu Shuangxing Color Plastic New Materials | 5.25B |
| MYS Group | 4.08B |
| Huangshan Novel Co.,Ltd | 4.03B |
| CIMC Safeway Technologies | 3.10B |
| Jiamei Food Packaging (Chuzhou) Co.,Ltd | 2.85B |